Abstract
The applications of nanoparticles in oncology include enhanced drug delivery, efficient tumor targeting, treatment monitoring, and diagnostics. The “theranostic properties” associated with nanoparticles have shown enhanced delivery of chemotherapeutic drugs with superior imaging capabilities and minimal toxicities. In conventional chemotherapy, only a fraction of the administered drug reaches the tumor site or cancer cells. For successful translation of these formulations, it is imperative to evaluate the design and properties of these nanoparticles. Here, we describe the design of ultra-small silica nanoparticles to encapsulate a radiosensitizing drug for combined chemoradiation therapy. The small size of nanoparticles allows for better dispersion and uptake of the drug within the highly vascularized tumor tissue. Silica nanoparticles are synthesized using an oil-in-water microemulsion method. The microemulsion method provides a robust synthetic route in which the inner hydrophobic core is used to encapsulate chemotherapy drug, docetaxel while the outer hydrophilic region provides dispersibility of the synthesized nanoparticles in an aqueous environment. Docetaxel is commonly used for treatment of resistant or metastatic prostate cancer, and is known to have radiosensitizing properties. Here, we describe a systematic approach for synthesizing these theranostic nanoparticles for application in prostate cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Bissery MC, Nohynek G, Sanderink GJ, Lavelle F (1995) Docetaxel (Taxotere): a review of preclinical and clinical experience. Part I: Preclinical experience. Anticancer Drugs 6:339–355
Bolla M, Hannoun-Levi JM, Ferrero J-M et al (2010) Concurrent and adjuvant docetaxel with three-dimensional conformal radiation therapy plus androgen deprivation for high-risk prostate cancer: preliminary results of a multicentre phase II trial. Radiother Oncol 97:312–317. doi:10.1016/j.radonc.2010.08.012
Kumar R, Roy I, Ohulchanskyy TY et al (2008) Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging. ACS Nano 2:449–456. doi:10.1021/nn700370b
Maitra A (1984) Determination of size parameters of water aerosol OT oil reverse micelles from their nuclear magnetic-resonance data. J Phys Chem 88:5122–5125. doi:10.1021/j150665a064
Najjar R (1970) Microemulsions—a brief introduction. Intech, Rijeka, Croatia
Peer D, Karp JM, Hong S et al (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2:751–760. doi:10.1038/nnano.2007.387
Prasad PN (2012) Introduction to nanomedicine and nanobioengineering. Wiley, Hoboken, NJ
Roy I, Kumar P, Kumar R et al (2014) Ormosil nanoparticles as a sustained-release drug delivery vehicle. RSC Adv 4:53498–53504. doi:10.1039/C4RA10293B
Sharma RK, Das S, Maitra A (2004) Surface modified ormosil nanoparticles. J Colloid Interface Sci 277:342–346. doi:10.1016/j.jcis.2004.04.019
Szakács G, Paterson JK, Ludwig JA et al (2006) Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5:219–234. doi:10.1038/nrd1984
Veronese FM, Mero A (2008) The impact of PEGylation on biological therapies. BioDrugs 22:315–329
Acknowledgment
This work was supported by NSF-DGE- 0965843 and ARMY/ W81XWH-12-1-0154.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Belz, J., Castilla-Ojo, N., Sridhar, S., Kumar, R. (2017). Radiosensitizing Silica Nanoparticles Encapsulating Docetaxel for Treatment of Prostate Cancer. In: Zeineldin, R. (eds) Cancer Nanotechnology. Methods in Molecular Biology, vol 1530. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6646-2_26
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6646-2_26
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6644-8
Online ISBN: 978-1-4939-6646-2
eBook Packages: Springer Protocols